View in EDS HTML Full Text PDF Full Text

Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study.

Saved in:
Bibliographic Details
Title: Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study.
Authors: Zhai, Tianyue1 (AUTHOR), Mitamura, Takashi1 (AUTHOR) takami@huhp.hokudai.ac.jp, Wang, Lei2,3 (AUTHOR), Kubota, Shimpei I.4,5 (AUTHOR), Murakami, Masaaki4,5,6,7 (AUTHOR), Tanaka, Shinya2,3 (AUTHOR), Watari, Hidemichi1 (AUTHOR)
Source: Cancer Medicine. Apr2023, Vol. 12 Issue 8, p9697-9708. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 163604650
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Zhai%2C+Tianyue%22">Zhai, Tianyue</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mitamura%2C+Takashi%22">Mitamura, Takashi</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> takami@huhp.hokudai.ac.jp</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Lei%22">Wang, Lei</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kubota%2C+Shimpei+I%2E%22">Kubota, Shimpei I.</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Murakami%2C+Masaaki%22">Murakami, Masaaki</searchLink><relatesTo>4,5,6,7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tanaka%2C+Shinya%22">Tanaka, Shinya</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Watari%2C+Hidemichi%22">Watari, Hidemichi</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancer+Medicine%22">Cancer Medicine</searchLink>. Apr2023, Vol. 12 Issue 8, p9697-9708. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=163604650
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cam4.5674
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 9697
    Titles:
      – TitleFull: Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhai, Tianyue
      – PersonEntity:
          Name:
            NameFull: Mitamura, Takashi
      – PersonEntity:
          Name:
            NameFull: Wang, Lei
      – PersonEntity:
          Name:
            NameFull: Kubota, Shimpei I.
      – PersonEntity:
          Name:
            NameFull: Murakami, Masaaki
      – PersonEntity:
          Name:
            NameFull: Tanaka, Shinya
      – PersonEntity:
          Name:
            NameFull: Watari, Hidemichi
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 04
              Text: Apr2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 20457634
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Cancer Medicine
              Type: main
ResultId 1